Scientific Publications by FDA Staff
Sci Transl Med 2012 Aug 29;4(149):149fs31
FDA oversight of cell therapy clinical trials.
Au P, Hursh DA, Lim A, Moos MC Jr, Oh SS, Schneider BS, Witten CM
The U.S. Food and Drug Administration applies regulatory flexibility to balance benefits and risks to subjects in cell-therapy clinical trials.
|Category: Journal Article, Editorial|
|PubMed ID: #22932219||DOI: 10.1126/scitranslmed.3004131|
|Includes FDA Authors from Scientific Area(s): Biologics|
|Entry Created: 2012-08-31||Entry Last Modified: 2013-01-18|